Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Month of birth and risk of multiple sclerosis in a Portuguese population.
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE).
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Multiple sclerosis care in Latin America.
A review of current and emerging therapeutic strategies in multiple sclerosis.
Astrocytic vesicle mobility in health and disease.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Current and emerging therapies in multiple sclerosis: a systematic review.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Treatment of chronic inflammatory polyneuropathy may improve associated hearing loss: A case report and a review of the literature.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
A Combined Inspiratory and Expiratory Muscle Training Program Improves Respiratory Muscle Strength and Fatigue in Multiple Sclerosis.
Stem cell therapy for central nerve system injuries: glial cells hold the key.
Inflammatory bowel disease: An archetype disorder of outer environment sensor systems.
The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review.
Pages
« first
‹ previous
…
244
245
246
247
248
249
250
251
252
…
next ›
last »